Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

HistoWiz Leadership

Zippia score 3.7
Job openings (4)
OverviewJobsRevenueReviews

CEO & Executives

HistoWiz executives

Here are further demographic highlights of the leadership team:
  • The HistoWiz executive team is 39% female and 61% male.
  • 50% of the management team is White.
  • 12% of HistoWiz management is Hispanic or Latino.
  • 8% of the management team is Black or African American.
Work at HistoWiz?
Share your experience

Rate HistoWiz's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Ke Cheng

Founder and President

Ke Cheng's LinkedIn

Suzanne Coberly

MD

Christopher Gibson

Board Member

Christopher Gibso is CSO and Chief Pathologist at histoWiz. He worked at Merck Research Labs in Palo Alto, California where he was involved in designing and validating IHC assays for their high-profile biologics, cancer, and immunology division. Chris has also worked at DuPont and served as Director of Toxicologic Pathology at the world-renowned Gene Therapy Program at the University of Pennsylvania. Chris has extensive knowledge in IHC, IF, ISH, target validation, tissue cross-reactivity, biomarkers, tox path, regulatory submissions, and GLP. Chris enjoys nature and the outdoors and balances his love of science with his need for creativity by woodworking, canoe-building, and classic truck restoration. Chris is a board-certified (ACVP) veterinary pathologist with experience in research pathology, pharmaceutical/biotech, chemical industry, and gene therapy. He received his veterinary degree from The University of Pennsylvania, completed an anatomic pathology residency at Tufts University and a PhD in toxicology at Rutgers University.

Julie Teruya-Feldstein

MD, Chief Pathologist

Adrien Cesaire

Board Member

David Gutman

MD

Jeff Shek

Lead Software Engineer

Jerry Kuang

COO

Jerry Kuang is a COO at HistoWiz and is based in New York City, New York. He attended Stanford University.

Matt Wilder

Board Member

Rafael Jimenez

MD

Do you work at HistoWiz?

Does the leadership team provide a clear direction for HistoWiz?

HistoWiz jobs

HistoWiz founders

Name & TitleBio
Ke Cheng

Founder and President

Ke Cheng's LinkedIn

HistoWiz board members

Name & TitleBio
Christopher Gibson

Board Member

Christopher Gibso is CSO and Chief Pathologist at histoWiz. He worked at Merck Research Labs in Palo Alto, California where he was involved in designing and validating IHC assays for their high-profile biologics, cancer, and immunology division. Chris has also worked at DuPont and served as Director of Toxicologic Pathology at the world-renowned Gene Therapy Program at the University of Pennsylvania. Chris has extensive knowledge in IHC, IF, ISH, target validation, tissue cross-reactivity, biomarkers, tox path, regulatory submissions, and GLP. Chris enjoys nature and the outdoors and balances his love of science with his need for creativity by woodworking, canoe-building, and classic truck restoration. Chris is a board-certified (ACVP) veterinary pathologist with experience in research pathology, pharmaceutical/biotech, chemical industry, and gene therapy. He received his veterinary degree from The University of Pennsylvania, completed an anatomic pathology residency at Tufts University and a PhD in toxicology at Rutgers University.

Adrien Cesaire

Board Member

David Gutman

MD

Matt Wilder

Board Member

HistoWiz executives FAQs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of HistoWiz, including salaries, political affiliations, employee data, and more, in order to inform job seekers about HistoWiz. The employee data is based on information from people who have self-reported their past or current employments at HistoWiz. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by HistoWiz. The data presented on this page does not represent the view of HistoWiz and its employees or that of Zippia.

HistoWiz may also be known as or be related to HistoWiz, HistoWiz, Inc., Histowiz and Histowiz, Inc.